Bayer AG: clinical-trial pipeline
Bayer AG is the sponsor of 1,674 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 90 are not yet finished and 4 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials90
Phase 2/3 and 3320
Countries97
New in 90 days4
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 632 |
| Phase 1 | 358 |
| Phase 3 | 314 |
| Phase 2 | 234 |
| Phase 4 | 110 |
| Phase 1/2 | 20 |
| Phase 2/3 | 6 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 1,458 |
| Terminated | 98 |
| Recruiting | 42 |
| Active, not recruiting | 37 |
| Withdrawn or not authorised | 28 |
| Not yet recruiting | 11 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 375 |
| Cardiovascular | 340 |
| Nephrology and urology | 218 |
| Women's health and obstetrics | 157 |
| Metabolic and endocrine (diabetes, obesity) | 107 |
| Neurology | 105 |
| Respiratory | 104 |
| Haematology | 84 |
| Ophthalmology | 75 |
| Gastroenterology and liver | 69 |
| Infectious disease and vaccines | 58 |
| Dermatology | 42 |
Countries
| Country | Trials |
|---|---|
| United States | 594 |
| Germany | 555 |
| Italy | 292 |
| Spain | 289 |
| France | 271 |
| United Kingdom | 268 |
| Japan | 267 |
| Canada | 228 |
| Belgium | 202 |
| Netherlands | 189 |
| Poland | 186 |
| South Korea | 185 |
| Austria | 168 |
| China | 161 |
| Sweden | 161 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-25 | New trial posted | A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2… |
| 2026-09-08 | New trial posted | A Study of Darolutamide Plus Androgen Deprivation Therapy in Patients With Metastatic Hor… |
| 2026-08-31 | New trial posted | An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for… |
| 2026-08-27 | New trial posted | Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05196035 | A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into,… | Phase 3 | Active, not recruiting | Argentina, Austria, Australia, Belgium +27 |
| NCT05457283 | A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an AC… | Phase 3 | Active, not recruiting | Argentina, Austria, Australia, Belgium +27 |
| NCT00161943 | A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Comb… | Phase 1 | Active, not recruiting | Belgium, China, Spain, United Kingdom +3 |
| NCT06452277 | A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment,… | Phase 3 | Recruiting | Argentina, Austria, Australia, Belgium +31 |
| NCT06659341 | A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers W… | Phase 1 | Recruiting | Australia, Denmark, Spain, United Kingdom +1 |
| NCT06854640 | A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With S… | Phase 1 | Active, not recruiting | Belgium, Germany, France, Netherlands +1 |
| NCT06760819 | A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it… | Phase 2 | Recruiting | Australia, Canada, Switzerland, China +7 |
| NCT06764316 | A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Ad… | Phase 1 | Recruiting | Belgium, Canada, China, Spain +5 |
| NCT06914128 | A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors | Phase 1/2 | Recruiting | Australia, Belgium, China, Czechia +9 |
| 2025-522336-14-00 | A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension. | Phase 1 | Not yet recruiting | Germany |
| NCT07192952 | A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatmen… | Phase 3 | Recruiting | Argentina, Austria, Belgium, Bulgaria +18 |
| NCT07188805 | A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Ou… | Phase 3 | Recruiting | Argentina, Austria, Belgium, Bulgaria +18 |
| 2024-516471-33-00 | (22419) A randomized, double-blind, placebo-controlled, parallel group Phase 2a study with an extension phase… | Phase 2 | Active, not recruiting | Czechia, Germany, Spain, France +3 |
| NCT07431294 | A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandocig… | Phase 1 | Not yet recruiting | Bulgaria, Germany |
| NCT07298044 | A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyre… | Phase 4 | Recruiting | Austria, Belgium, Germany, Italy +1 |
| 2025-524043-12-00 | A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together… | Phase 1 | Recruiting | Germany |
| NCT07535112 | A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastat… | Phase 1 | Recruiting | Australia, Belgium, Denmark, Spain +6 |
| 2026-525569-30-00 | A study to learn how a high-fat meal affects the way elinzanetant is taken up by the body in healthy women | Phase 1 | Active, not recruiting | Germany |
| NCT07625215 | A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation | Phase 2 | Recruiting | Belgium, Bulgaria, Germany, Hungary +4 |
| NCT04519619 | Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG) | Not applicable | Recruiting | Japan |
| NCT05900388 | A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thr… | Not applicable | Not yet recruiting | Denmark, Spain, France, Sweden |
| NCT07753252 | Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body | Phase 1 | Recruiting | United States |
| NCT06075147 | The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Vi… | Not applicable | Active, not recruiting | United Arab Emirates, Australia, Canada, Switzerland +14 |
| NCT06052306 | A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affec… | Phase 1 | Active, not recruiting | Canada, Finland, United Kingdom, Netherlands |
| NCT05537740 | A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alo… | Phase 1 | Active, not recruiting | Belgium, Canada, China, Spain +4 |
Website: bayer.com. All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Bayer AG clinical trials: 90 open, 320 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/bayer-com/, data as of 2026-10-25.